COVID-19 Vaccines Regulatory Status Update - SAHPRA Review Details
Update on COVID-19 vaccine regulatory status as of January 25, 2021, provided by Dr. B. Semete-Makokotlela, SAHPRA CEO. The update includes information on vaccine applications submitted to SAHPRA, regulatory reviews conducted, and Section 21 applications for vaccines like Janssen, AstraZeneca, and C
1 views • 13 slides
Guidelines for Researchers Requesting Permission in District Yusuf Moosa
Roles and responsibilities of the District Research Committee (DRC) in the Johannesburg Health District, including reviewing research proposals, granting permission for studies, and ensuring ethical and regulatory compliance. Researchers must provide HREC and SAHPRA approvals, research protocol, stu
0 views • 9 slides
Enhancing Regulatory Oversight in Medicines and Healthcare
The MCC faces challenges in quality reviews, timeliness, transparency, responsiveness, and capacity. Identified gaps include the regulation of complementary medicines, African traditional medicines, medical devices, and more. Efforts to address these gaps involve the establishment of SAHPRA and init
0 views • 18 slides